Private Equity Brussels: Top Firms in 2026

Key Facts: Belgium's Private Equity Market

• Belgium counts 17 or more active private equity firms, with industry databases tracking up to 30 of the largest by capital deployed across all regions.
• Belgium's PE industry association reports €25.7 billion invested in Belgian companies since 2007, spanning venture capital, growth equity, and buyout activity across every major sector.
• Fund sizes range from approximately $141M (Vectis Private Equity) to over €14 billion in net asset value (Groupe Bruxelles Lambert), reflecting the coexistence of boutique and large-cap strategies in one market.
• Brussels is the dominant hub, home to eight of the largest firms by AUM, including GBL, Cobepa, NXMH, Sofina, M80 Partners, and Finance&Invest.Brussels.
• Evergreen and permanent capital structures are increasingly replacing closed-end fund models among Belgium's most established PE managers, with GBL, Cobepa, and Sofina all operating under perpetual capital frameworks.
• Healthcare, technology, and business services attract the highest deal concentration, with leading Belgian fund managers extending their investment thesis into France and DACH alongside domestic Benelux mandates.
• PE and venture capital-backed companies in Belgium collectively employ over 237,000 people across 1,165 businesses, reflecting the sector's direct operational footprint in the national economy.

Private Equity Brussels: Market Overview

Brussels concentrates more private equity capital than any other Belgian city, with eight of the country's largest firms by net asset value headquartered within the capital region. The city's draw is structural: proximity to EU institutions creates a regulatory intelligence advantage, and the density of multinational headquarters generates consistent deal flow for mid-market and large-cap managers alike. Finance&Invest.Brussels, the region's government-backed investment vehicle, further anchors the ecosystem by supporting early-stage and SME companies that institutional funds typically cannot address.

Belgium's broader PE market spans a fund size range from €140 million to €14 billion in NAV, with €25.7 billion deployed since 2007. The market is growing, with cross-border expansion into France and DACH accelerating across multiple firms, and evergreen structures gaining share over traditional ten-year closed-end fund models. Antwerp serves as the country's second hub, anchored by Gimv (listed on Euronext Brussels), Finco, and Down 2 Earth Capital; Diegem hosts Sofindev and Vendis Capital, while smaller Flemish mid-market operators are spread across Heverlee, Aalter, and Strombeek-Bever.

A defining characteristic of Belgium's PE landscape is the prevalence of family-backed and permanently capitalized vehicles alongside institutional closed-end funds. Cobepa is backed by entrepreneurial families across five European nationalities, while Capnor combines family office agility with institutional discipline. Both represent a model that prioritizes long holding periods and founder partnership over financial engineering. This structural diversity, from listed holding companies to government-backed venture vehicles, distinguishes the Belgian market from more homogeneous PE ecosystems elsewhere in Europe.

Firm Comparison at a Glance

The Belgian PE market spans five distinct capital structures. The firms below represent those with verifiable strategy, sector, and location data. AUM figures reflect the most recent available data (2024-2025).

The table reveals a clear divide between large permanently capitalized vehicles (GBL, Cobepa) and mid-market operators with undisclosed or smaller AUM (M80, Capnor, Vendis). Firms without AUM data are nonetheless active deal-makers: M80 Partners completed five transactions between 2023 and 2025 across healthcare services, facility management, and public affairs.

Top Picks by Investment Strategy

Largest NAV: Groupe Bruxelles Lambert (GBL) at €14B net asset value, combining listed equity stakes in adidas, Pernod Ricard, and SGS with direct private asset positions in Affidea, Canyon, Sanoptis, and Voodoo.

Evergreen Capital Leader: Cobepa, with €5.1B NAV and a permanent capital base backed by entrepreneurial families from Belgium, Germany, the UK, France, and Luxembourg, offering portfolio companies flexible investment horizons unavailable from closed-end funds.

Top Listed Growth Equity Platform: Gimv, the only Belgian PE firm trading publicly on Euronext Brussels, manages a €2 billion portfolio across 64 companies with a combined turnover of €4.5 billion and deploys up to €150M per deal across five focused sector platforms.

Strongest Mid-Market Operator: M80 Partners, targeting companies with an enterprise value between €25M and €250M in healthcare, business services, and manufacturing across Benelux and France, with a verified track record in SD Worx, Le Pain Quotidien, and LASEA.

Best for Brussels-Region SMEs: Finance&Invest.Brussels, the government-backed development finance institution active since 1984, offering equity, loans, and guarantees specifically for Brussels-region businesses from early stage through growth.

Deepest Sector Specialist: Finco, with $180M in AUM and an exclusive focus on banking, insurance, asset management, and fintech, is the only Belgian PE manager dedicated entirely to financial services sector investments.

Ideal for Patient Co-Investment Access: Capnor, combining €5-50M equity tickets across direct investments, co-investments, and fund-of-funds with a family-backed mandate built for long-term partnerships without exit pressure.

Top Belgium PE Firms in Detail

Groupe Bruxelles Lambert (GBL)

Belgium's most capitalized investor by net asset value sits at the intersection of listed equity and direct private ownership. With €14 billion in NAV and a 70-year stock exchange listing history, GBL holds significant stakes in global listed companies including adidas, Pernod Ricard, SGS, Imerys, and Umicore. The firm also maintains direct private asset positions in Affidea, Canyon, Parques Reunidos, Sanoptis, and Voodoo, with a dedicated vehicle, GBL Capital, managing indirect private asset exposure for additional diversification. GBL's structure is distinctive: it combines the governance transparency of a listed company with a long-term family shareholder base that prevents short-term capital allocation pressure.

Cobepa

The benchmark for evergreen private equity in Belgium, Cobepa manages €5.1 billion in net asset value from offices in Brussels and New York, backed by entrepreneurial families across five European nationalities through the Cobehold holding structure. Its permanent capital base means portfolio companies face no artificial exit timeline, a material advantage over institutional investors operating within standard ten-year fund windows. The 2023 exit of Scalian demonstrates Cobepa's capacity for large-cap trade sales: sold to Wendel after significant value creation, the transaction confirmed the firm's ability to execute when value has been fully realized. Current holdings include Socotec, Precision Orthopedics, and Reaction Biology, reflecting a diversified international mandate across growth-stage businesses.

Gimv

The only Belgian PE manager trading publicly on Euronext Brussels, Gimv gives investors liquid access to a €2 billion portfolio spanning 64 holdings with a combined annual turnover of €4.5 billion. Gimv runs five dedicated investment platforms: Consumer, Healthcare, Life Sciences, Smart Industries, and Sustainable Cities. Each platform operates with specialist teams deploying equity tickets up to €150M per deal. This platform model creates genuine depth rather than a generalist approach: Gimv's Healthcare team backed Spineart in orthopedic implants, while its Smart Industries platform supported Variass and Televic. Antwerp-based and targeting Benelux, France, and DACH, Gimv occupies the mid-market growth equity space where institutional deal flow is richest.

Sofindev

Sofindev's defining credential is operational consistency: the Diegem-based buyout firm concluded its Sofindev IV fund in June 2024, deploying capital across Belgian and pan-European mid-market companies with a "tailor-made human approach" to value creation. With $676M in assets under management across current and historical funds, Sofindev invests across a diversified mandate in companies including Altenova, Delta Engineering, Euphoria Mobility, and Polysto. The firm occupies the buyout and growth equity segment below Gimv's threshold, making it a natural partner for Belgian management teams pursuing MBOs or owners seeking a structured secondary buyout exit. The Sofindev IV close confirms continued GP fundraising momentum in the Belgian mid-market.

M80 Partners

M80 Partners stands apart from Belgian peers through a documented ESG commitment that goes beyond compliance. The Brussels-based firm is a Principles for Responsible Investment (PRI) signatory and a signatory to the Initiative Climat International, publishing annual sustainability reports since 2021. Its investment thesis targets companies with enterprise values between €25M and €250M across healthcare, business services, and manufacturing. The firm deploys €10-60M equity per transaction, covering Benelux and France. The portfolio reflects both strategic depth and breadth: Le Pain Quotidien (brand restructuring), Theuma (Belgian market leader in wooden doors), LASEA (precision laser micromachining for luxury and medtech), and a co-investment in SD Worx alongside CVC through Brabo Investments. M80 Partners is the strongest choice for mid-market founders in healthcare or services who need a cross-border partner with demonstrated French deal execution.

Finance&Invest.Brussels

No other PE institution in Belgium carries a mandate as specific as Finance&Invest.Brussels: government-backed since 1984, it exists exclusively to provide capital to Brussels-region businesses through equity stakes, loans, and guarantees. The instrument flexibility sets it apart from institutional private equity, where equity is typically the sole lever. Early-stage companies that lack the scale for institutional deal flow, and growth-stage businesses building within the Brussels Capital Region, benefit from a limited partner whose return objectives align with regional economic development rather than fund-level IRR maximization. Finance&Invest.Brussels is the natural first call for Brussels-based founders seeking institutional backing without the dilution pressure of commercial PE.

Capnor

Capnor occupies a structural niche that few Belgian managers can match: it operates simultaneously as a direct investor, co-investor alongside trusted partner funds globally, and fund-of-funds manager, all under one family-backed umbrella. Equity tickets range from €5M to €50M, covering the lower mid-market segment that larger PE vehicles routinely pass over. The six-sector focus covers Healthcare, Business Services, Industrials, Technology, Consumer, and Financial Services. Each sector maps to specific investment criteria: B2B or B2B2C business models, organic expansion potential, and committed founder-led management. Business owners who want patient capital over financial engineering will find Capnor's permanent capital model materially different from conventional closed-end buyout funds, and the multi-instrument flexibility reinforces that distinction.

Sofina

Sofina's competitive position in Belgian PE derives from time horizon rather than capital scale. The Brussels-based holding company takes long-term minority stakes in growth-stage businesses, reinvesting dividends and gains across a diversified portfolio without the exit pressure inherent in fund structures. This evergreen growth equity model has compounded quietly over decades, positioning Sofina alongside GBL and Cobepa as one of Belgium's three flagship permanently capitalized investment vehicles. Founders and family-owned businesses considering a minority sale to an institutional investor will find Sofina's approach fundamentally different from buyout-oriented PE: the firm seeks alignment with existing management rather than operational control, making it suitable for companies at scale that need expansion capital without relinquishing majority ownership.

Rivean Capital

Rivean Capital brings four decades of operational history to the Belgian mid-market, having been active since 1982 from its base in Berchem-Sainte-Agathe. Sector focus and current AUM are not publicly disclosed, but its deal history across 26 portfolio companies and 15 M&A transactions positions Rivean among the more experienced buyout operators in the Belgian market. The firm's longevity through multiple economic cycles, including the 2008 financial crisis and the post-pandemic leveraged buyout environment, constitutes a track record that newer entrants cannot replicate. For advisors and management teams seeking a Belgian-rooted PE partner, Rivean's long institutional memory and established Benelux deal network make it a credible addition to any shortlist.

Investment Trends and Capital Flows

Evergreen Structures Displacing Closed-End Funds

The dominant structural trend in Belgian PE is the move away from ten-year limited fund windows toward permanently capitalized vehicles. GBL, Cobepa, and Sofina collectively manage tens of billions in perpetual capital, a model increasingly preferred by founder and family sellers who want a buyer aligned with long-term value rather than fund-cycle exit pressure. This alignment advantage generates higher deal flow for evergreen vehicles, particularly in family-owned business transitions where sellers can negotiate without artificial timelines.

Healthcare and Medtech Consolidation

Healthcare is the most active sector by deal count among Belgian PE managers. Gimv's dedicated Healthcare and Life Sciences platforms have backed Spineart and Biotalys; M80 Partners' investment in Rigolo Comme La Vie (nurseries) and LASEA (medtech laser technology) reflects cross-sector healthcare exposure; Capnor lists healthcare as its primary direct investment focus. The 2025 Equine Care Group expansion, backed by Gimv and CNP, points to continued commitment to consolidation plays in niche healthcare subsectors.

ESG Integration and SFDR Compliance

ESG reporting has moved from voluntary best practice to regulatory baseline for Belgian PE fund managers. All EU-domiciled funds must comply with the Sustainable Finance Disclosure Regulation (SFDR), with Article 8 and Article 9 classifications now standard due diligence questions from limited partners. M80 Partners is a PRI signatory publishing annual sustainability reports, Cobepa has formalized its ESG strategy, and Invest Europe publishes an annual ESG Reporting Template as a harmonized KPI framework for Belgian and European managers.

Buy-and-Build in Fragmented Sectors

Platform acquisition followed by add-on acquisitions is the dominant value creation mechanism for mid-market Belgian PE. Sofindev's portfolio of industrial and engineering businesses and M80's multi-company healthcare services strategy both rely on buy-and-build models to grow EBITDA through consolidation rather than organic growth alone. Fragmented service sectors, including IT services, healthcare services, and property management, are the primary targets, offering multiple arbitrage between sub-scale acquisition prices and consolidated exit valuations.

Cross-Border Expansion into France and DACH

Belgian PE deal flow increasingly extends beyond Benelux into France and the DACH region. M80 Partners carries an explicit Benelux-France mandate and has demonstrated exits in French portfolio companies including Eurodommages and Strapharm. Gimv targets Benelux, France, and DACH simultaneously from its Antwerp base, while Cobepa sources international transactions from both Brussels and New York. This cross-border expansion reflects both a search for larger deal pipelines and the natural geography of Belgian founders building pan-European businesses.

How to Evaluate PE Investors in Belgium

Track record of operational value creation, not just financial engineering, is the primary differentiator among Belgian PE managers. Request evidence of portfolio company revenue and EBITDA growth during ownership, plus headcount expansion and management retention. These are more reliable signals than realized returns alone, which are often selectively disclosed. Check membership with Belgium's PE industry association and Invest Europe affiliation as baseline credibility markers for any firm under consideration.

Fund structure is a decisive criterion that is systematically underweighted by founders. An evergreen vehicle like Cobepa or Capnor has no structural pressure to sell within a fixed window. This translates into real flexibility on timelines, reinvestment decisions, and exit routes. By contrast, a closed-end fund in years seven through nine of a ten-year cycle faces incentive misalignment. The GP's carried interest depends on completing exits before wind-down, creating pressure that may not align with portfolio company interests.

ESG commitment depth matters beyond surface-level compliance. Request each firm's SFDR Article classification: Article 8 signals ESG integration into investment decisions, while Article 9 signals a sustainability objective as the primary mandate. Red flags include no ESG policy, opaque fund structures with no disclosed LP base, and portfolios where the firm's stated sector expertise does not match the actual deal history. For mid-market deals in Belgium, PE deal databases provide AUM benchmarks and portfolio history that allow direct comparison across active managers.

Which Firm Fits Your Needs?

Brussels-based founders seeking their first institutional capital have a government-backed starting point that requires no competitive fundraising process. Finance&Invest.Brussels offers equity, loans, and guarantees calibrated to SME scale, without the return-maximization pressure of commercial PE. Companies scaling past the €10M revenue threshold should consider M80 Partners and Sofindev as the most active mid-market operators. Both carry sector depth in healthcare and business services alongside Benelux-France deal track records.

LPs building a Belgian or Benelux PE allocation have one listed option and several unlisted routes. Gimv on Euronext Brussels provides daily liquidity and a disclosed NAV across 64 portfolio companies, making it the only institutional-quality liquid vehicle in the market. For unlisted exposure, Cobepa and GBL represent Belgium's permanent capital blue chips, while Capnor offers a more granular entry point with its €5-50M ticket range and access to a curated global co-investment network.

Business owners considering a partial or full sale to a PE buyer should calibrate the firm's fund structure against their own timeline preferences. Patient sellers who want a multi-year partnership before any exit event are better served by Cobepa, Sofina, or Capnor. A mid-life closed-end fund facing LP distribution pressure creates misaligned incentives. Advisors sourcing pan-European mandates from Belgium can anchor on GBL and Cobepa for large-cap cross-border deals. Cobepa's dual Brussels-New York presence makes it especially accessible for international counterparties.

Methodology

This guide to private equity in Brussels covers Belgium-headquartered and Brussels-active investment firms with a verifiable investment mandate and either disclosed AUM, portfolio data, or documented deal history. Firm data was drawn from PE industry databases, fund performance databases, industry fundraising rankings, firm websites, and Belgium's PE industry association statistics for the period 2021-2025, with fund data current to Q1 2026. Firms were evaluated across six criteria: AUM and fund structure, sector focus, cross-border activity, ESG commitment, deal history, and management team stability. The selection includes both Brussels-city firms and Belgium-wide managers with primary operations from Brussels, reflecting the geographic concentration documented in the market data. Readers should verify fund status directly with each firm before initiating any investment process.